Nuveen Asset Management, LLC Aveo Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.21 - $7.45 $455,497 - $546,450	-73,349 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$5.97 - $15.28 $41,306 - $105,722	-6,919 Reduced 8.62%	73,349 $537,000
Q4 2020 Feb 16, 2021	BUY	$5.08 - $6.68 $94,650 - $124,461	18,632 Added 30.23%	80,268 $463,000
Q3 2020 Nov 16, 2020	BUY	$4.16 - $6.26 $115,048 - $173,126	27,656 Added 81.39%	61,636 $366,000
Q2 2020 Aug 14, 2020	BUY	$3.47 - $9.99 $117,910 - $339,460	33,980 New	33,980 $175,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.